Integrity Financial Corp »

Abcellera Biologics shares owned by Integrity Financial Corp

Quarter-by-quarter ownership of Abcellera Biologics (ABCL) shares owned by Integrity Financial Corp from 13F filings

Historical chart of Integrity Financial Corp investment in Abcellera Biologics

Tip: Access up to 7 years of quarterly data

All positions including Abcellera Biologics held by Integrity Financial Corp consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Abcellera Biologics by Integrity Financial Corp

Quarter filed Position value Share count Share price at filing
2023-12-31 $69k 12k 5.71
2023-09-30 $60k 13k 4.60

More positions owned by Integrity Financial Corp

Spdr S&p 500 Etf Tr Tr Unit (SPY)
First Tr Exchange-traded Cap Strength Etf (FTCS)
Ishares Tr Msci Intl Qualty (IQLT)
First Tr Exchng Traded Fd Vi Cboe Vest Fd Dep (BUFD)
Invesco Qqq Tr Unit Ser 1 (QQQ)
First Tr Value Line Divid In SHS (FVD)
Apple (AAPL)
Microsoft Corporation (MSFT)
First Tr Exchng Traded Fd Vi Cboe Vest Us Eq (BUFR)
First Tr Exchange Traded Intl Equity Opp (FPXI)
First Tr Exchange-traded Senior Ln Fd (FTSL)
Brown & Brown (BRO)
First Tr Exchng Traded Fd Vi Vest Us Buffer (FAUG)
Wisdomtree Tr Em Ex St-owned (XSOE)
Fs Kkr Capital Corp (FSK)

View all positions for Integrity Financial Corp

Top funds holding Abcellera Biologics

Baillie Gifford & Co
Baker Bros. Advisors
Credit Suisse
OrbiMed Advisors
Arrowpoint Asset Management
Founders Fund VII Management
Lazard Asset Management
Federated Investors
Casdin Capital
Guardian Capital Advisors
Millennium Management
Two Sigma Investments
Citadel Advisors
Two Sigma Advisers
Norges Bank Investment Management

View all funds holding Abcellera Biologics